[ad_1]
On the 18th of last month, Vice President Mihee Cho of Poonglim Pharmatech, which is a minimal residual type (LDS) syringe production facility for corona 19 vaccination in Gunsan, Jeollabuk-do, is comparing the minimal residual type syringe (left) with a general syringe. The red reagent remains when the piston is fully pushed into a conventional syringe, but little remains in the minimal residual syringe. Yunhap news
Eun-kyung Jung, head of the COVID-19 vaccination promotion team (Director of the Korea Centers for Disease Control and Prevention) clarified the policy that in exceptional cases additional administration of vaccines other than vaccines will be implemented the designated number per bottle. It is explained that it is a principle to administer up to a certain number of people, and that additional personnel are inoculated only when there is sufficient amount remaining or when it is necessary to minimize the amount of waste.
At a ‘Corona 19 Vaccination and Prevention Promotion Progress’ briefing on Day 1, Director Jung said: “In principle, it is a rule to inoculate corona 19 vaccine according to content and usage. of the original license “. He said.
The AstraZeneca Corona 19 vaccine contains 10 people per vial (vial) and the Pfizer vaccine contains 6 people. However, if a general syringe is used, a small amount is added in the process of withdrawing the drug from the vial and giving the injection, so manufacturers add slightly more drug than the prescribed dose.
Currently, the minimal residual type (LDS) syringe used for corona 19 vaccination in Korea has greatly reduced the amount of additional input, so there may be more vaccine left in the vial than when using a general syringe . Consequently, the Korean Centers for Disease Control and Prevention sent an official letter so that the remaining amount of vaccine in a vial could be used for vaccination at the discretion of the medical field. In this way, up to 12 people with the AstraZeneca vaccine and 7 people with the Pfizer vaccine can be administered per vial.
In contrast, in the medical community, there is a burden that vaccination personnel have to leave a residual amount for one dose, and concern has been raised that the risk of contamination may increase if multiple vials of vaccine are mixed together to increase the residual amount. .
In this regard, the director of Promotional Chung said: “Officially, the dose used per vial (one dose) is not increased.” The official number of AstraZeneca vaccines is 10 people and Pfizer is 6 people, and it will not increase evenly. However, “it means that the remaining amount can be used to minimize the amount of waste in the field, such as when the subdivision was not properly subdivided one by one or only one more person needs to be vaccinated but a new vaccine needs to be opened.” He added: “The principle is that even if the remaining amount is used, the dose of the other inoculum must be observed, and there is absolutely no way to make an additional inoculum by mixing several vials.”
The Ministry of Food and Pharmaceutical Safety prescribed the dose per person when approving the Pfizer and AstraZeneca vaccine. “We do not judge that it is a question of permission (how many people are vaccinated per vial), but we will discuss it with the Ministry of Food and Drug Safety.”
Lim So-hyung reporter [email protected]
News directly edited by Hankook Ilbo can also be viewed on Naver.
Issues that may interest you
[ad_2]
